Vote of Confidence from Big Pharma CEOs at China Development Forum
ASEAN Pharma: Novartis’ $256M Singapore Manufacturing Expansion; Filipino ‘Pharma Ecozones’; Korea to Invest in Region?
Changing Ourselves to Change the World: Engaging in India’s Pharma Development Strategy
Chinese Pharma News: Drug Research Slows; Global Deals Targeted; Homeland Security Concerns
Clinical Trials in India: A New Era of R&D
BeiGene: China’s Biotech Darling Sees Product Sales Reach USD 2.2 bn as Expansion Continues
South Korea’s Reform to Boost Doctors’ Numbers Backfires with Walkouts
India: An Attractive Proposition for Global Pharma’s Latest Innovations?
China Pharma News: US Bill Pinpoints WuXi as “Foreign Adversary Biotech;” Novartis Acquires SanReno
2 Big Pharma Country Manager Moves to China
Japanese Academic Clinical Data Can Now Be Used for Drug Registration
APAC Pharma Roundup: Celltrion Sells Takeda Portfolio; Novartis Strikes a Deal with Chong Kun Dang
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here